Skip to content

Clinical trials

Phase 3 Glaucoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glaucoma Phase: Phase 3 Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20036
20043
20057
200610
20079
20086
20092
20109
20113
20126
20133
20147
20154
20164
20173
20184
20193
20213
20222
20231
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Unknown status14
Terminated10
Recruiting6
Withdrawn2
Suspended2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research23
Allergan12
Pro Top & Mediking Company Limited8
Glaukos Corporation4
Merck Sharp & Dohme LLC4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Aerie Pharmaceuticals3
Laboratoires Thea3
Laboratorios Sophia S.A de C.V.3
Singapore Eye Research Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glaucoma118
Ocular Hypertension65
Glaucoma, Open-Angle38
Hypertension9
Cataract7
Pterygium4
Glaucoma, Angle-Closure2
Exfoliation Syndrome1
Eye Diseases1
Fibrosis1

Trials

Showing 76 to 100 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.